Probiotics for your lungs
ResBiotic is pioneering microbiome-based products for respiratory health.
Transforming the $100B+ Respiratory Disease Market by Tackling a Primary Cause
Chronic respiratory illness is associated with lung dysbiosis (also known as an abnormal lung microbiome) in addition to local and systemic inflammation. An abnormal microbiome induces further inflammation, creating a downward spiral. Enter ResBiotic: probiotics that break the cycle by modulating the inflammation of the body.
Fully Integrated with the resources of University of Alabama at Birmingham
As the flagship brand of ResBiotech Innovation Institute, ResBiotic is supported by:
Bill Harbert Insititute for Innovation and Entrepreneurship
Licensing and commercialization
UAB Medicine
Lung Health
Center
Scientific Research,
Lung Health
UAB School of Medicine Microbiome
Center
Scientific Research,
Microbiome
Translational Research in Normal & Disordered Development
Scientific Research,
Human Development
Product Pipeline
ResBiotic is developing dietary supplements, medical foods, and pharmabiotics to support lung health.
Probiotic Supplement
Our first product is a dietary supplement, targeting the gut lung axis with a proprietary probiotic blend clinically proven to support lung health.
Medical Foods
Our pipeline of medical foods includes proprietary synbiotic and nutritional formulas for individuals with chronic lung diseases.
Pharmabiotic
Our research and development pipeline also includes prescription grade probiotics to be administered via the inhalation route.
Lung Health Starts Here
Join us in revolutionizing the standard of care for chronic respiratory diseases.